Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gustafsson

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Seminars in Vascular Medicine|August 27, 2005
Discovery of ximelagatran in an historical perspectiveDavid Gustafsson
Thrombosis Research|June 24, 2003
The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-reviewDavid Gustafsson, Margareta Elg
Thrombosis Research|May 5, 2005
A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in ratsMargareta Elg, David Gustafsson
BMC Nephrology|July 31, 2013
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalityDavid Gustafsson, Robert Unwin
Ambio|March 6, 2007
Modeling carbon turnover in five terrestrial ecosystems in the boreal zone using multiple criteria of acceptanceLouise Karlberg, David Gustafsson, Per-Erik Jansson
Advanced Materials (Deerfield Beach, Fla.)|December 23, 2016
A Vertical Organic Transistor Architecture for Fast Nonvolatile MemoryXiao-Jian She, David Gustafsson, Henning Sirringhaus
International Journal of Molecular Sciences|April 3, 2021
The Role of BDNF in Experimental and Clinical Traumatic Brain InjuryDavid Gustafsson, Andrea Klang, Sebastian Thams, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical EfficacyCecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Respiratory Physiology & Neurobiology|January 27, 2025
Breathlessness dimensions should be evaluated in relation to the level of exertion: A clinical studyViktor Elmberg, Gufran Ali, David Gustafsson, et al.
ERJ Open Research|December 28, 2023
The modified Medical Research Council scale misclassifies exertional breathlessness among people referred for exercise testingDavid Gustafsson, Viktor Elmberg, Linus Schiöler, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Seminars in Vascular Medicine|August 27, 2005
Discovery of ximelagatran in an historical perspectiveDavid Gustafsson
Thrombosis Research|June 24, 2003
The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-reviewDavid Gustafsson, Margareta Elg
Thrombosis Research|May 5, 2005
A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in ratsMargareta Elg, David Gustafsson
BMC Nephrology|July 31, 2013
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalityDavid Gustafsson, Robert Unwin
Ambio|March 6, 2007
Modeling carbon turnover in five terrestrial ecosystems in the boreal zone using multiple criteria of acceptanceLouise Karlberg, David Gustafsson, Per-Erik Jansson
Advanced Materials (Deerfield Beach, Fla.)|December 23, 2016
A Vertical Organic Transistor Architecture for Fast Nonvolatile MemoryXiao-Jian She, David Gustafsson, Henning Sirringhaus
International Journal of Molecular Sciences|April 3, 2021
The Role of BDNF in Experimental and Clinical Traumatic Brain InjuryDavid Gustafsson, Andrea Klang, Sebastian Thams, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical EfficacyCecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Respiratory Physiology & Neurobiology|January 27, 2025
Breathlessness dimensions should be evaluated in relation to the level of exertion: A clinical studyViktor Elmberg, Gufran Ali, David Gustafsson, et al.
ERJ Open Research|December 28, 2023
The modified Medical Research Council scale misclassifies exertional breathlessness among people referred for exercise testingDavid Gustafsson, Viktor Elmberg, Linus Schiöler, et al.
Pageof 4